Sti571/Cgp57148b T35717+Caps


Indications and Reactions:

Role Indications Reactions
Primary
Chronic Myeloid Leukaemia 28.7%
Gastrointestinal Stromal Tumour 21.2%
Acute Lymphocytic Leukaemia 14.2%
Prostate Cancer 12.2%
Infection Prophylaxis 4.0%
Hypertension 3.0%
Gastritis Prophylaxis 2.0%
Hypoaesthesia 2.0%
Insomnia 2.0%
Acute Myeloid Leukaemia 1.5%
Prostate Cancer Metastatic 1.2%
Back Pain 1.0%
Constipation Prophylaxis 1.0%
Gastrooesophageal Reflux Disease 1.0%
Metastatic Neoplasm 1.0%
Neoplasm 1.0%
Anaemia 0.7%
Atrial Fibrillation 0.7%
Cardiac Failure 0.7%
Gastric Neoplasm 0.7%
Vomiting 18.0%
Death 11.3%
Weight Decreased 9.0%
Pyrexia 7.5%
White Blood Cell Count Decreased 6.0%
Swelling 5.3%
Sepsis 4.5%
Thrombocytopenia 4.5%
Ileocolectomy 3.8%
Headache 3.0%
Lipase Increased 3.0%
Penis Carcinoma 3.0%
Rales 3.0%
Staphylococcal Infection 3.0%
Thyroid Neoplasm 3.0%
Urinary Bladder Haemorrhage 3.0%
Cholecystitis Acute 2.3%
Eye Swelling 2.3%
Lung Consolidation 2.3%
Malignant Neoplasm Progression 2.3%
Secondary
Gastrointestinal Stromal Tumour 29.5%
Chronic Myeloid Leukaemia 16.0%
Infection Prophylaxis 11.5%
Gastritis Prophylaxis 5.8%
Hypoaesthesia 5.8%
Insomnia 5.8%
Acute Lymphocytic Leukaemia 4.1%
Constipation Prophylaxis 2.9%
Prostate Cancer 2.9%
Gastrooesophageal Reflux Disease 2.3%
Headache 2.2%
Diabetes Mellitus 1.8%
Eyelid Oedema 1.8%
Face Oedema 1.8%
Atrial Fibrillation 1.3%
Anaemia 1.1%
Cardiac Failure 1.1%
Myasthenia Gravis 0.9%
Thrombosis Prophylaxis 0.9%
Desmoid Tumour 0.5%
Wheezing 16.3%
Ileocolectomy 10.9%
Weight Decreased 9.2%
White Blood Cell Count Decreased 8.7%
Road Traffic Accident 6.5%
Thyroid Neoplasm 6.5%
Pyrexia 5.4%
Vomiting 5.4%
Death 3.8%
Vasoconstriction 3.8%
Eye Swelling 3.3%
Malignant Neoplasm Progression 2.7%
Proteinuria 2.7%
Speech Disorder 2.7%
Liver Function Test Abnormal 2.2%
Oedema 2.2%
Renal Failure Acute 2.2%
Swelling 2.2%
Sinus Tachycardia 1.6%
Tinnitus 1.6%

Drug Data